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Abstract
Background: Preoperative patients' characteristics can predict the need for perioperative blood
component transfusion in cardiac surgical operations. The aim of this prospective observational
study is to identify perioperative patient characteristics predicting the need for allogeneic packed
red blood cell (PRBC) transfusion in isolated primary coronary artery bypass grafting (CABG)
operations.
Patients and Methods: 105 patients undergoing isolated, first-time CABG were reviewed for
their preoperative variables and followed for intraoperative and postoperative data. Patients were
97 males and 8 females, with mean age 58.28 ± 10.97 years. Regression logistic analysis was used
for identifying the strongest perioperative predictors of PRBC transfusion.
Results: PRBC transfusion was used in 71 patients (67.6%); 35 patients (33.3%) needed > 2 units
and 14 (13.3%) of these needed > 4 units. Univariate analysis identified female gender, age > 65
years, body weight ≤ 70 Kg, BSA ≤ 1.75 m2, BMI ≤ 25, preoperative hemoglobin ≤ 13 gm/dL,
preoperative hematocrit ≤ 40%, serum creatinine > 100 μmol/L, Euro SCORE (standard/logistic) >
2, use of CPB, radial artery use, higher number of distal anastomoses, and postoperative chest tube
drainage > 1000 mL as significant predictors. The strongest predictors using multivariate analysis
were CPB use, hematocrit, body weight, and serum creatinine.
Conclusion: The predictors of PRBC transfusion after primary isolated CABG are use of CPB,
hematocrit ≤ 40%, weight ≤ 70 Kg, and serum creatinine > 100 μmol/L. This leads to better
utilization of blood bank resources and cost-efficient targeted use of expensive blood conservation
modalities.
Introduction
Blood component transfusion has been an important part
of coronary artery bypass graft surgery (CABG) since its
inception [1]. Transfusion rates in cardiac surgery remain
high despite major advances in perioperative blood con-
servation and institutions continue to vary significantly in
their transfusion practices for CABG surgery [2-7]. The
mean number of packed red blood cells (PRBCs) trans-
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the frequency of transfusion ranges from 16% to 100%
[1]. The National Blood Service for England issues approx-
imately 2.2 million units of blood a year, of which 10%
are used in cardiac surgical units [8,9]. Nearly 20% of all
blood transfusions in the United States are associated
with cardiac surgery [7,10].
In the early days of CABG, almost all patients received
blood components or whole blood. However, despite cur-
rent reductions in transfusion requirements for patients
undergoing CABG, many patients continue to require
transfusion [1]. Not all patients are at the same risk for
transfusion requirement. Some patient variables can be
used to predict the risk for perioperative transfusion [11].
Although often life-saving, blood transfusions are associ-
ated with significant risk to the patient and escalating
costs to the blood bank system and hospital [12]. The
risks associated with the use of allogeneic blood product
transfusion include ABO/Rh incompatibility, sepsis,
febrile reactions, immunosuppression, and viral transmis-
sion [10,13]. Transmission of hepatitis B and C and HIV
by transfusion occurs in 1 in 300 000 cases, despite
screening programs. Non-fatal but serious transfusion
errors occur in 1 in 16 000 transfusions [14]. Blood trans-
fusions have been linked to increased morbidity and mor-
tality [15]. Homologous transfusions are
immunosuppressive and associated with a higher risk of
postoperative infection [16]. In addition, blood transfu-
sion during or after coronary artery bypass operations
were associated with increased length of intensive care
unit and hospital stay [17]and long-term mortality
[15,17,18]. Moreover, stored red cells undergo progressive
structural and functional changes over time. In cardiac
surgical patients, transfusion of red cells that had been
stored for more than 2 weeks was associated with a signif-
icantly increased risk of postoperative complications as
well as reduced short-term and long-term survival [19].
This is maybe explained by the fact that transfusion of old
blood causing microvascular obstruction secondary to
free cell fragments and strong proinflammatory effect
[20,21]. Stored blood contains extracellular bioactive sub-
stances: Plasminogen Activator Inhibitor-1 (PAI-1) and
IL-1beta which increase with the duration of blood stor-
age [22]. Additionally, blood transfusion is a costly trans-
plantation of tissue that may endanger the health of the
recipient [23].
A number of pharmacologic and non-pharmacologic
(mechanical) methods for reducing transfusion require-
ments are currently used [1]. Pharmacologic products to
decrease blood use include 1-deamino-8-D-arginine vaso-
pressin (DDAVP), tranexamic acid, epsilon-aminocaproic
acid, and aprotinin [13]. The foremost mechanical meth-
ods of perioperative conservation of red blood cells are
autologous blood donation, acute perioperative normov-
olemic hemodilution and intraoperative blood salvage
[9,24,25]. The adoption of available blood conservation
techniques, either alone or in combination, in patients
undergoing cardiac surgery, could result in an estimated
75% reduction of unnecessary transfusions [7]. Both
pharmacological and mechanical blood conservation
methods have cost implications [9]. Preoperative identifi-
cation of those at high risk for blood transfusion will
allow for the use of cost-effective blood conservation
modalities [11,26].
The aim of this prospective observational study is to iden-
tify preoperative (demographic, clinical, laboratory),
intraoperative and postoperative patient characteristics
predicting the need for allogeneic packed red blood cell
(PRBC) transfusion in isolated, primary coronary artery
bypass grafting in our local cardiac surgical service.
Patients and methods
Patient Population
After hospital's ethics committee approval, this prospec-
tive observational study included all patients who under-
went first-time isolated coronary artery bypass grafting at
North West Armed Forces Hospital, Tabuk, Saudi Arabia,
during the period from May 2003 to April 2005 (n = 105).
Patients were reviewed for their preoperative demo-
graphic, clinical (surrogate coronary artery disease severity
and co morbidity) and laboratory variables and then fol-
lowed till discharge to record their intraoperative data and
postoperative outcomes.
All the patients included in the study were managed
according to the hospital's current policies regarding pre-
operative preparation, intraoperative surgical and anes-
thetic management, and postoperative care.
Surgical Technique
All the patients included in this study were operated upon
by one surgical team. Operations were done either on-
pump or off-pump. Routinely, left internal mammary
artery was used as in-situ pedicled graft for the left anterior
descending coronary artery. Arterial conduits (right inter-
nal mammary artery and radial artery conduit) were used
whenever possible according to patient's characteristics
and saphenous vein grafts were used for completion of
revascularization.
Preoperative Preparation
All cardiac medications were continued till the day of sur-
gery except for antiplatelet drugs which were stopped 5
days prior to surgery in elective patients except when the
expected risk of acute coronary events was higher than risk
of bleeding. Risk stratification of patients was done byPage 2 of 11
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study, emergency CABG was defined as surgical interven-
tion indicated within 72 hours from coronary angio-
graphic diagnosis or acute coronary event to prevent death
or major morbidities.
Anesthetic Technique
Anesthetic technique was standardized in all patients.
Patients were premedicated with midazolam 7.5 mg
orally the night before surgery and morphine 10 mg intra-
muscularly 30 minutes before sending the patient to
theater. Anesthesia was induced with midazolam 0.05 –
0.1 mg/kg, fentanyl 5 – 10 μg/kg, and propofol 1 – 2 mg/
kg. Pancuronium 0.15 mg/kg was used to facilitate
endotracheal intubation and mechanical ventilation.
Patients were mechanically ventilated to keep EtCO2
between 30 – 35 mmHg. Anesthesia was maintained with
sevoflurane 1 – 1.5 MAC and N2O 50% in oxygen. Fenta-
nyl and pancuronium supplements were administered as
required.
Conventional On-pump CABG
On-pump CABG operations were done via median ster-
notomy. After Heparin was given in a dose of 300 IU/kg
to reach target activated clotting time ≥ 480 seconds, car-
diopulmonary bypass (CPB) was established. Moderate
hypothermia (28 – 32°C) was used throughout CPB. The
prime volume of the circuit consisted of 1,500 mL of Plas-
malyte-A and 25 gm of mannitol. Blood was added to
keep hematocrit (Hct) on the CPB around 20 – 22%. Cold
antegrade multidose blood cardioplegia (Modified St.
Thomas cardioplegic solution) was used to induce and
maintain diastolic cardiac arrest. Mean arterial blood pres-
sure was kept at 50 – 70 mmHg. After the conclusion of all
anastomoses and termination of CPB, intravenous pro-
tamine was used to neutralize circulating heparin.
Off- pump CABG
Off-pump patients were operated upon through median
sternotomy. After harvesting conduits and making peri-
cardial sling, heparin 150 IU/kg was administered, and
supplemental doses were added, as needed, to maintain
activated clotting time (ACT) between 200 – 250 seconds.
Different Maneuvers have been used to help exposure of
the target vessels like Medtronic Octopus III, Starfish
Repositioner, deep pericardial stitch and Intracoronary
shunts. After completing of the anastomoses, the total
dose of heparin was reversed with protamine (1:1 ratio).
ICU Management
Patients were transferred to ICU intubated and were
mechanically ventilated until they were ready for wean-
ing. Monitoring, sedation, analgesia, and inotropic and
vasoactive drug administration were managed according
to ICU protocols.
Blood Conservation Techniques
For on-pump operations, moderate hemodilution was
used during CPB. All blood remaining in the circuit of
CPB was retransfused to the patient at the end of the pro-
cedure. In off-pump cases, cell saver (Brat 2 Autologous
Blood Recovery System, Cobe Cardiovascular, Inc.,
Arvada, CO, USA) was routinely used except for cases that
needed only one anastomosis (LIMA-to-LAD grafting).
No prophylactic antifibrinolytic medications were used
during the entire period of the study.
Transfusion Guidelines
Blood was transfused during CPB if hematocrit value was
less than 20% and/or hemoglobin was less than 7 gm.
Postoperatively, blood transfusion was started if hemo-
globin was less than 8 gm and/or hematocrit was less than
25% according to the departmental protocol unless the
patient was showing signs of hemodynamic instability or
ongoing bleeding. Usually two units of packed RBCs were
used in a single transfusion setting.
Study Design
The study endpoint was packed red blood cell (PRBC)
transfusion. Data were reported both categorically (i.e.
whether PRBCs were used or not) and quantitatively
(number of units transfused). Clinical events such as reex-
ploration for bleeding, morbidity and mortality were
reported. Multivariate logistic regression models were
built to assess the predictors of packed red blood cell
transfusion. The transfusion of fresh frozen plasma and
platelets was not included in this analysis.
Statistical Methods
SPSS for Windows, Release 7.5.1, statistical package
(SPSS, Inc., Chicago, IL, USA) was used for statistical anal-
ysis. Patients' preoperative, intraoperative and postopera-
tive variables and PRBC transfusion data were presented
as mean ± SD or number (%) as appropriate. Student's t-
test or Mann-Whitney U test were used to compare
numerical variables and Pearson chi-square test, Yates'
correction, or Fisher's exact test were used to compare
ordinal variables between transfused and non-transfused
patient population. Then, logistic regression analysis was
performed to select the best predictors of PRBC transfu-
sion. Univariate analysis was done first to detect signifi-
cant predictors, followed by multivariate regression
analysis models. Continuous variables were analyzed
twice, first as continuous and then as dichotomous varia-
bles. Cut points were derived from mean, median, high or
low normal, or previously defined values. A P value < 0.05
was considered significant.
Results
This prospective observational study comprised 105
patients presenting for primary isolated coronary arteryPage 3 of 11
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(92.4%) and 8 females (7.6%), with mean age 58.28 ±
10.97 (range, 31 – 90) years. CABG operations were either
elective (82 patients, 78.1%) or emergency (23 patients,
21.9%). On-pump operations were 48 (45.7%) and the
remaining 57 (54.3%) were done off-pump. The number
of distal anastomoses ranged from 1 – 5, with a mean of
3.02 ± 0.88. In patients who underwent on-pump CABG,
mean CPB time was 99.53 ± 24.13 minutes and mean aor-
tic cross-clamp time was 62.85 ± 21.06 minutes.
Of the 105 patients included, packed red blood cell
(PRBC) transfusion was utilized in 71 patients (67.6%).
Thirty-five patients (33.3%) received more than 2 units of
PRBCs; of these, 14 patients (13.3%) received more than
4 units. A total of 227 units of PRBCs were used, with a
mean of 2.16 ± 2.25 units per patient. The mean number
PRBC units received was 1.21 ± 1.58 in off-pump patients
and 3.27 ± 2.45 in on-pump patients (P = 0.026) (figure
1).
All the eight female patients included in the study (8/8,
100%) received PRBC transfusion compared with 63 male
patients (63/97, 64.9%). Patients who received PRBC
transfusions had significantly older age and lower body
weight, body surface area (BSA), body mass index (BMI),
and preoperative hemoglobin (Hb) and hematocrit (Hct).
Transfused and non-transfused patient populations didn't
differ significantly as regards height, platelet count, Pro-
thrombin time (PT), Partial Thromboplastin time (PTT),
serum creatinine, and serum albumin. Associated co mor-
bidity percentages were comparable in transfused and
non-transfused groups, including current smoking, diabe-
tes mellitus, hypertension, cerebrovascular disease,
chronic obstructive pulmonary disease, and peripheral
vascular disease.
Also, transfused patients had significantly higher Euro
SCORE (logistic and standard) compared with non-trans-
fused patients. Left ventricular ejection fraction (LVEF)
was comparable in transfused and non-transfused
patients. Number of patients who were receiving heparin
in the preoperative period and those in whom antiplatelet
therapy was continued in the last 5 preoperative days were
comparable in transfused and non-transfused popula-
tions. Surgical intervention was elective in 76.1% (54/71)
and emergency in 23.9% (17/71) of transfused patients
while in non-transfused patients surgery was elective in
82.4% (28/34) and emergency in 17.6% (6/34) (P =
0.47). CPB was used in 57.7% (41/71) of transfused
patients and in only 20.6% (7/34) of non-transfused
patients (P = 0.0003). Patients who received perioperative
PRBC transfusions had more distal anastomoses than
patients who were not transfused (3.14 ± 0.88 vs. 2.76 ±
0.82, respectively, P = 0.04). Use of variable types of con-
duits for grafting was comparable in transfused and non-
transfused patients, except for the radial artery (used in
74.6% of transfused and 50% of non-transfused patients,
P = 0.01). In on-pump patients, CPB time and aortic cross
Packed red blood cell transfusion dataFigure 1
Packed red blood cell transfusion data. Of the 105 patients included, packed red blood cell (PRBC) transfusion was uti-
lized in 71 patients (67.6%). Thirty-five patients (33.3%) received more than 2 units of PRBC; of these, 14 patients (13.3%) 
received more than 4 units.
 2 units , 36 
patients , 34.3%
3 - 4 units , 21 
patients , 20%
> 4 units , 14 
patients , 13.3%
Trans fus ed, 71 
patients , 67.6%
Not Trans fused, 
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transfused and non-transfusion patients.
Postoperatively, patients who received PRBC transfusions
had significantly higher chest tube drainage than those
who were not transfused (1005 ± 727 vs. 632 ± 207 mL).
PRBC transfusion was significantly associated with pro-
longed intubation time and hospital stay, but not Cardiac
Surgical Unit (CSU) stay. Perioperative myocardial infarc-
tion, neurologic dysfunction, pneumonia, wound infec-
tion, and mediastinitis didn't show a significant
association with transfusion. In-hospital mortality was
recorded in 4 patients (3.8%), all of them received PRBC
transfusion (P > 0.05).
Using derived cut points, transfused patient population,
compared to non-transfused, included significantly more
patients > 65 years old (33.8% vs. 14.7%), ≤ 70 kg body
weight (60.6% vs. 23.5%), ≤ 1.75 m2 BSA (60.6% vs.
35.3%), ≤ 25 BMI (43.7% vs. 11.8%), ≤ 13 gm/dL Hb
(43.7% vs. 23.5%), ≤ 40% Hct (59.2% vs. 29.4%), > 100
μmol/L creatinine (38% vs. 11.8%), > 2 Euro Score
(standard, 57.7% vs. 32.4%; logistic, 53.5% vs. 32.4%), ≥
1000 mL postoperative chest tube drainage (35.2% vs.
5.9%).
Table 1. Is showing pre-operative patients' characteristics,
operative surgical data and post-operative outcome data.
Univariate analysis showed that significant preoperative
predictors of perioperative PRBC transfusion were: female
gender, age > 65 years, body weight ≤ 70 Kg, BSA ≤ 1.75
m2, BMI ≤ 25, preoperative hemoglobin ≤ 13 gm/L, hema-
tocrit ≤ 40, serum creatinine > 100 μmol/L, and Euro
SCORE (logistic/standard) > 2. Significant intraoperative
and postoperative predictors were use of cardiopulmo-
nary bypass, higher number of distal anastomoses, radial
artery use, and postoperative chest tube drainage > 1000
mL.
By multivariate regression analysis, the strongest predic-
tors of blood transfusion were the use of CPB (P =
0.0001), preoperative hematocrit ≤ 40 (P = 0.002), body
weight ≤ 70 kg (P = 0.01), and serum creatinine > 100 (P
= 0.01) (Table 2).
Discussion
The use of allogeneic blood transfusion after coronary
artery surgery is still high despite published transfusion
guidelines and costly blood conservation strategies
[27,28]. Readily available patient variables can predict
patients at risk for transfusion [29]. The classification of
coronary artery bypass graft patients on the basis of
attributes known preoperatively and by conduits used
yields subsets of patients with distinctly different transfu-
sion requirements and in-hospital outcomes [30].
Prediction models based on preoperative variables may
facilitate blood component management and improve the
efficiency of ordering blood before operations for patients
undergoing CABG surgeries in order to assist blood banks
in improving responsiveness to clinical needs [1,31].
Two patterns are usually prevailing for preoperative blood
component stocking and preparation in cardiac surgical
patients. One practice is the cross-matching of a large
number (4 or more) of PRBC units that are usually – at
least in part – not utilized, leading to wasting blood bank
efforts and resources, including time, space, and reagents.
The other is cross-matching a limited number of units
(usually 2 units of PRBCs) and typing an extra 2 units to
be cross-matched at need. This may lead to a blood bank
emergency when a patient is in urgent need for blood
component transfusion, putting a considerable stress and
time load on the blood bank team. A model to predict
patients at risk of requiring more than the standard
number of blood components would alleviate plenty of
blood bank stress, save time and resources, and allow bet-
ter utilization of available space and blood resources [1].
Blood conservation has become one of the most impor-
tant issues in cardiac surgery [29,32]. Some of blood con-
servation strategies are cost-efficient and simple to utilize
and can be employed in nearly all cardiac surgical patients
without adding further risk to the patient or effort to the
operating room team, including non-hemic prime of car-
diopulmonary bypass machine, salvage of blood from
surgical field using cardiotomy suction, hemodilution
during CPB, retransfusion of all contents of oxygenator at
the end of CPB, and use of ultrafiltration and modified
ultrafiltration during and after CPB. Use of other modali-
ties, such as antifibrinolytic therapy, preoperative autolo-
gous blood donation, use of cell saving devices, and auto
transfusion of shed mediastinal chest tube drainage is still
limited owing to doubts about their effectiveness and
inappropriateness for use in many patients [8,33-36]. In
addition, the routine use of such expensive and sophisti-
cated techniques in all cardiac surgical patients causes
higher cost exceeding the benefit obtained. So, these strat-
egies should be utilized more critically [37].
The use of predictors of allogeneic PRBC use in CABG
patients allows for preoperative risk stratification and may
allow for more rational resource allocation of costly blood
conservation strategies [28]. Identifying high-risk patients
for transfusion would alter perioperative patient manage-
ment and allow the employment of a multimodality
approach to blood conservation resulting in a lower trans-
fusion rate at a reasonable cost-efficiency [38].
In our study, 67.6% (71 patients) of all patients undergo-
ing primary isolated CABG operations either on pump orPage 5 of 11
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Table 1: Preoperative patients' characteristics, operative surgical data, and post-operative outcome data.
Variable Total Transfusion No Transfusion P Value
Gender Male 97 (92.4%) 63 (88.7%) 34 (100%) 0.1002
Female 8 (7.6%) 8 (11.3%) 0 (0%)
Age (years) Mean ± SD 58.28 ± 10.97 60.46 ± 10.69 53.73 ± 10.36 0.0028
≤ 65 years 76 (72.4%) 47 (66.2%) 29 (85.3%) 0.0405
> 65 years 29 (27.6%) 24 (33.8%) 5 (14.7%)
Weight (Kg) Mean ± SD 72.67 ± 14.81 69.76 ± 12.05 78.74 ± 18.10 0.0032
≤ 70 51 (48.6%) 43 (60.6%) 8 (23.5%) 0.0003
> 70 54 (51.4%) 28 (39.4%) 26 (76.5%)
B.S.A. (Kg/m2) Mean ± SD 1.75 ± 0.15 1.72 ± 0.15 1.79 ± 0.11 0.0249
≤ 1.75 55 (52.4%) 43 (60.6%) 12 (35.3%) 0.0152
> 1.75 50 (47.6%) 28 (32.4%) 22 (64.7%)
B.M.I. Mean ± SD 27.07 ± 4.18 26.39 ± 4.52 28.49 ± 2.96 0.0155
≤ 25 35 (33.3%) 31 (43.7%) 4 (11.8%) 0.0011
> 25 70 (66.7%) 40 (56.3%) 30 (88.2%)
Hb (gm/dL) Mean ± SD 13.59 ± 1.52 13.31 ± 1.59 14.18 ± 1.18 0.0055
≤ 13 39 (37.1%) 31 (43.7%) 8 (23.5%) 0.0457
> 13 66 (62.9%) 40 (56.3%) 26 (76.5%)
Hct (%) Mean ± SD 39.18 ± 4.00 38.42 ± 4.07 40.99 ± 3.21 0.0062
≤ 40 52 (49.5%) 42 (59.2%) 10 (29.4%) 0.0043
> 40 53 (50.5%) 29 (60.8%) 24 (70.6%)
Creatinine (μmol/L) Mean ± SD 106.79 ± 83.58 106.63 ± 53.82 107.12 ± 125.98 0.9780
≤ 100 74 (70.5%) 44 (62%) 30 (88.2%) 0.0057
> 100 31 (29.5%) 27 (38%) 4 (11.8%)
Type of surgery On-pump 48 (45.7%) 41 (57.7%) 7 (20.6%) 0.0003
Off-pump 57 (54.3%) 30 (42.3%) 27 (79.4%)
Use of RA 70/105 (66.7%) 53/71 (74.6%) 17/34 (50%) 0.0121
Number of distal anastmoses 3.02 ± 0.88 3.14 ± 0.88 2.76 ± 0.82 0.0390
CPB time (min) 99.53 ± 24.13 104.85 ± 24.88 98.60 ± 24.22 0.4731
Ao × time (min) 62.85 ± 21.06 64.74 ± 19.87 51.85 ± 25.86 0.1347
Intubation time (hours) 29.24 ± 78.06 37.11 ± 94.28 13.03 ± 5.680 0.03674
CSU stay (days) 7.31 ± 15.40 7.54 ± 16.25 6.85 ± 13.66 0.8227
Hospital stay (days) 9.19 ± 6.82 9.90 ± 8.08 7.67 ± 1.77 0.0294
Postoperative blood loss
Mean ± SD 883.59 ± 632 1005 ± 727 632 ± 207 0.0043
≤ 1000 mL 78 (74.3%) 46 (64.8%) 32 (94.1%) 0.0012
> 1000 mL 27 (25.7%) 25 (35.2%) 2 (5.9%)
Data are presented as mean ± SD or No. (%).
B.S.A.: Body Service Area. B.M.I.: Body Mass Index.
Hb: Hemoglobin. Hct: Hematocrit.
RA: Radial Artery.
CPB time: Cardiopulmonary Bypass time.
Ao × time: Aortic cross clamp time. CSU: Cardiac Surgery Unit.
Journal of Cardiothoracic Surgery 2009, 4:20 http://www.cardiothoracicsurgery.org/content/4/1/20off-pump received PRBC transfusion, 33.3% of the total
number (35 patients) needed more than 2 units, and only
13.3% (14 patients) needed more than 4 units of PRBCs.
The mean number of PRBC units received was 2.16 ± 2.25
unit per 
patient.
The strongest predictors of PRBC use in our study were the
use of CPB (P = 0.0001), preoperative hematocrit ≤ 40 (P
= 0.0021), body weight ≤ 70 kg (P = 0.0105), serum creat-
inine > 100 μmol/L (P = 0.0142). Other predictors
included female gender, age > 65 years, BSA ≤ 1.75 m2,
BMI ≤ 25, hemoglobin ≤ 13 gm/dL, Euro SCORE > 2,
radial artery use, and higher number of distal anastomo-
ses (a cut point could not be derived).
Current smoking; associated comorbidities (including
diabetes mellitus, hypertension, cerebrovascular disease,
COPD and peripheral vascular disease); preoperative
platelet count, PT, PTT, and serum albumin; left ventricu-
lar EF; type of intervention (elective/emergency); type of
conduits used (apart from radial artery); and duration of
CPB and aortic cross-clamping were not significant pre-
dictors for PRBC transfusion in our patients. Also, preop-
erative use of heparin or continuation of antiplatelet
treatment beyond the last 5 preoperative days didn't prove
as significant predictors of PRBC transfusion.
Clinical studies conducted to identify perioperative risk
factors and predictors of blood component use in cardiac
surgical procedures varied widely regarding study designs,
surgical procedure characteristics, study period, and study
end points.
In a Japanese study, Isomatsu et al. (2001) [32] studied 89
patients undergoing isolated CABG surgery over 2 years,
from 1997 to 1999, to determine preoperative predictors
Table 2: Transfusion risk and regression logistic analysis of perioperative variables associated with blood transfusion.
Variable Transfusion vs. No Transfusion Transfusion Risk Univariate Analysis Multivariate Analysis
t-test X2 OR CI (95%) Numerical Categorical
Gender - 0.1002 - - - 0.014
Age 0.0028 0.0405 2.962 1.017 – 8.625 0.0050 0.0335
B.M.I. 0.0155 0.0011 5.813 1.852 – 18.244 0.0212 0.0026
B.S.A. 0.0249 0.0152 2.815 1.204 – 6.582 0.0288 0.0169
Hemoglobin 0.0055 0.0457 2.519 1.003 – 6.325 0.0077 0.0493
Euro SCORE (standard) 0.0052 0.0149 2.858 1.210 – 6.747 0.0082 0.0166
Euro SCORE (logistic) 0.0200 0.0571 2.408 1.022 – 5.670 0.0284 0.0444
No. of Distal anastomoses 0.0390 - - - 0.0431 -
Radial artery use - 0.0121 2.944 1.247 – 6.951 - 0.0137
Postoperative bleeding 0.0043 0.0012 8.696 1.922 – 39.335 0.0086 0.0050
Use of CPB - 0.0003 5.271 2.028 – 13.704 - 0.0007 0.0001
Hematocrit 0.0062 0.0090 3.476 1.447 – 8.350 0.0013 0.0039 0.0021
Weight 0.0032 0.0003 4.991 1.980 – 12.579 0.0093 0.0007 0.0105
S. creatinine 0.9780 0.0005 4.602 1.460 – 14.506 0.9778 0.0092 0.0142
B.M.I: Body Mass index.
B.S.A: Body surface area.
CPB: Cardiopulmonary Bypass.Page 7 of 11
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Of these, 66 patients (74%) received transfusion during
hospitalization. Independent predictors were emergency
surgery, lower hematocrit, older age, and presence of
peripheral vascular disease. Optimal cutoff of hematocrit
was 39% and age 64 years.
Karkouti et al. (2001) [26] studied all patients undergoing
elective first-time CABG surgery prospectively from Janu-
ary 1997 to September 1998 in Ontario, Canada. Transfu-
sion rate was 29.4 percent. Predictors included
preoperative hemoglobin, weight, age, and sex.
In a retrospective analysis of 400 consecutive patients
undergoing CABG, including emergency and re-opera-
tions, Litmathe et al. (2003) [11] found that 132 patients
(33%) received PRBC transfusion during hospitalization.
On average, 2.2 ± 0.68 units of red cell concentrate were
transfused per patient. Predictive parameters were age >
70 years, preoperative hemoglobin < 11 gm/dL, reopera-
tion, and ejection fraction < 0.35. The authors could not
find any significantly increased red cell concentrate trans-
fusion in female cases, insulin dependent diabetes melli-
tus, or impaired renal function.
Scott et al. (2003)[39] studied impact of CPB, hematocrit,
gender, age, and body weight on blood use in 1235 con-
secutive patients undergoing primary CABG over a period
of 2 years under on-pump or off-pump technique. PRBC
transfusion was used in 72.5% of on-pump patients com-
pared with 45.7% of off-pump patients. A lower percent-
age of males (52.6%) than females (79.4%) received
transfusion. Use of CPB, preoperative hematocrit < 35%,
female gender, increasing age (≥ 65 years), and decreased
body weight (≤ 83 Kg) were significant predictors of trans-
fusion. The strongest predictors of PRBC transfusion were
preoperative Hct < 35% and use of CPB.
Arora et al., in 2004 [28], studied 3,046 consecutive, iso-
lated CABG patients over 3 years to identify independent
predictors of allogeneic blood product transfusion. Allo-
geneic blood was used in 23% of all patients and 16.9%
of isolated, elective, first-time CABG cases. Independent
predictors of blood product usage were preoperative
hemoglobin 12 gm/dL or less, emergent operation, renal
failure, female sex, age 70 years or older, left ventricular
ejection fraction 0.40 or less, redo procedure, and low
body surface area. The authors validated this model on
2,117 consecutive isolated CABG patients.
Al-Shammari et al. (2005) [40] reviewed the medical
records of 159 consecutive primary CABG patients retro-
spectively to determine the perioperative factors associ-
ated with intraoperative blood transfusion. Overall, 128
(80.5%) patients received blood product transfusion
intraoperatively, 113 (70.5%) of them received PRBCs
and the remaining received fresh frozen plasma and plate-
lets. Moreover, 23 patients (12.6%) received more than
two PRBC units intraoperatively. Totally, 159 patients
consumed 342 units of PRBCs at an average of 2.1 units
per patient. Significant factors associated with intraopera-
tive RBC transfusion were: age > 60 years, female gender,
preoperative hemoglobin < 12 gm/dL, and 3 or more cor-
onary bypass grafts constructed.
McDonald and McMillan, in 2005 [41], utilized the prod-
uct of BSA (m2) and preoperative hemoglobin (gm/L) as
an index for intraoperative blood transfusion, the Trans-
fusion Predictor Product (TPP). For patients with TPP less
than 211.7 units, 46% received blood transfusion intraop-
eratively. At a TPP greater than 211.7 units, 6% of patients
had intraoperative blood transfusion. They suggested that
patients with a TPP > 211.7 do not require routine cross-
matching of blood.
The role of increased postoperative chest tube drainage
should be considered as the cause of lowering postopera-
tive hemoglobin/hematocrit to the level necessitating
PRBC transfusion according to the transfusion guidelines
employed and not as a predictor.
Preoperative coagulation parameters (platelet count, PT,
PTT) couldn't prove to be significant predictors for PRBC
use in our study. This can be explained by the very small
number of patients in our study with subnormal platelet
count or prolonged PT and PTT due to our center's adher-
ence to a strict policy regarding preoperative coagulation
status. In elective cases, antiplatelets are stopped for at
least 5 days preoperatively except if strongly indicated,
highest PT and PTT allowed for CABG surgery is 15 sec-
onds and 44 seconds, respectively, and the lowest platelet
count accepted is 150 × 103/L. In emergency cases,
patients not fulfilling these criteria are usually postponed
for few hours up to 72 hours for control of their coagula-
tion parameters unless earlier/immediate surgical inter-
vention is indicated. This accounts to the narrow range
reported in this study for PT (9 – 15 seconds) and PTT (28
– 46 seconds), thus ameliorating the effect of these other-
wise important parameters as predictors of bleeding/
transfusion.
Although use of CPB and number of distal anastomoses
are intraoperative events, rather than preoperative; yet, in
the vast majority of cases, both are usually planned from
preoperative parameters (including patient's general con-
dition and demographic variables, left ventricular func-
tion, and coronary angiography data about number and
sites of diseased coronary vessels). Changes from off-
pump to on-pump and omitting anastomoses based on
intraoperative findings and/or events are usually keptPage 8 of 11
(page number not for citation purposes)
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tal anastomoses still maintain their validity as preopera-
tive predictors for blood preparation and use of blood
conservation modalities.
Radial artery use was found statistically significant as a
predictor for PRBC use in the perioperative setting. This
could not be explained in light of previous researches or
literature. We couldn't determine if this was a mere coin-
cidental association or due to the association of radial
artery use with other verified predictors for transfusion,
e.g. number of distal anastomoses and use of CPB.
We chose body weight (and not BSA or BMI) for analysis
in most models owing to the fact that univariate analysis
and multivariate analysis proved that weight is a stronger
predictor for PRBC transfusion than BSA and BMI. Also,
Hct was used in most multivariate analysis models instead
of Hb as it was a stronger predictor for transfusion than
Hb by univariate analysis.
The strongest predictor of PRBC use in our study was the
use of CPB. Of 48 patients in whom CPB was used, 41
(85.4%) received PRBC transfusion compared with 30
patients (52.6%) of 57 off-pump patients. Off-pump
CABG eliminates the risks of cardiopulmonary bypass and
the systemic inflammatory response it elicits [42].
A retrospective review of 744 patients undergoing multi-
vessel CABG either on-pump (n = 609) or off-pump (n =
135) was carried out by Kshettry et al. (2000) [43]. Postop-
erative blood loss and use of blood transfusions were sig-
nificantly less in patients operated upon off-pump.
Three other studies were in agreement with our results.
Nuttal et al. (2003) [44] retrospectively studied charts of
200 adult patients who underwent CABG either on-pump
or off-pump. Although heparin was not reversed at the
end of OPCAB patients, OPCAB surgery was associated
with an overall reduction in allogeneic transfusion
requirements.
In a large series, Frankel et al. (2005) [42] compared 3646
off-pump CABG patients with a contemporaneous con-
trol group of 5197 on-pump CABG patients. Off-pump
CABG was associated with a lower need for single and
multiple unit postoperative blood transfusions compared
to on-pump CABG patients.
On the contrary, Gerola et al. (2004) [45], in a multicenter
randomized study on 160 selected low-risk patients
undergoing CABG on-pump (80 patients) or off-pump
(80 patients), did not find any statistical difference in
blood component use between on-pump and off-pump
patients; 43.7% of on-pump patients and 43% of off-
pump patients received blood component transfusion.
Number of blood units used in on-pump patients was 2.9
± 1.8 unit per patient and 2.2 ± 1.3 unit per patient in off-
pump patients.
In our study, out of 620 units of PRBCs cross-matched for
105 patients undergoing first-time isolated CABG (4 units
for patients) according to our hospital's policy, only 192
units were transfused (30.9%) and another 35 units were
cross-matched and transfused in the 14 patients who
received > 4 units of PRBCs. This reflects the necessity of
developing a blood reservation policy considering
patients individually based on their predicted transfusion
risks. Such a policy would have saved > 50% of blood
bank's efforts and resources.
Among the limitations of this study is the small number
of patients included due to the small size of our center's
target population. Another limitation is restricting the
study to PRBC transfusion predictors only. There is a
strong need in our center for determining the predictors of
fresh frozen plasma and platelet transfusion in cardiac
surgical procedures. The cost-efficiency of application of a
blood conservation strategy targeting patients at risk of
transfusion needs verification through prospective clinical
studies.
Conclusion
Need for PRBC transfusion in isolated, first-time CABG
patients can be predicted preoperatively. The strongest
predictors are use of CPB, hematocrit ≤ 40%, body weight
≤ 70 Kg, and serum creatinine > 100 μmol/L. Female gen-
der, older age, higher Euro SCORE, and number of distal
anastomoses are also significant predictors. Ability to
identify patients at risk of PRBC transfusion would save
blood bank efforts and resources and allow the employ-
ment of a targeted blood conservation policy in CABG
patients.
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